This selection ignores that the anti-AβO nAbs shown to protect neural cells from the toxic effects of AβOs and fibrils, and improve cognitive functions in AD transgenic mice, recognize the Aβ mid-/C-terminal rather than the Aβ1-15 region. The gene discussed is ABO; the disease is Alzheimer disease.